HRH1 and multiple sclerosis: Moreover, hydroxyzine (H1R antagonist), the compound AVN-101 (H1R ligand), GSK247246, and GSK239512 (H3R inverse agonists) are under clinical testing in patients with relapsing–remitting or progressive forms of multiple sclerosis [23].